The Evaluation of Surrogate Endpoints

Both humanitarian and commercial considerations have spurred intensive search for methods to reduce the time and cost required to develop new therapies. The identification and use of surrogate endpoints, i.e., measures that can replace or supplement other endpoints in evaluations of experimental tre...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Burzykowski, Tomasz (Επιμελητής έκδοσης), Molenberghs, Geert (Επιμελητής έκδοσης), Buyse, Marc (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2005.
Σειρά:Statistics for Biology and Health,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Setting the Scene
  • Regulatory Aspects in Using Surrogate Markers in Clinical Trials
  • Notation and Motivating Studies
  • The History of Surrogate Endpoint Validation
  • Validation Using Single-trial Data: Mixed Binary and Continuous Outcomes
  • A Meta-analytic Validation Framework for Continuous Outcomes
  • The Choice of Units
  • Extensions of the Meta-analytic Approach to Surrogate Endpoints
  • Meta-analytic Validation with Binary Outcomes
  • Validation in the Case of Two Failure-time Endpoints
  • An Ordinal Surrogate for a Survival True Endpoint
  • A Combination of Longitudinal and Survival Endpoints
  • Repeated Measures and Surrogate Endpoint Validation
  • Bayesian Evaluation of Surrogate Endpoints
  • Surrogate Marker Validation in Mental Health
  • The Evaluation of Surrogate Endpoints in Practice: Experience in HIV
  • An Alternative Measure for Meta-analytic Surrogate Endpoint Validation
  • Discussion: Surrogate Endpoint Definition and Evaluation
  • The Promise and Peril of Surrogate Endpoints in Cancer Research.